Ascletis Pharma Inc. (ASCLF)

Ascletis Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 23, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	779	374	195	661	459	407
Market Cap Growth	91.83%	91.83%	-70.51%	44.13%	12.73%	-3.58%
Enterprise Value	512	86	-153	287	56	-17
Last Close Price	0.88	0.24	0.17	0.55	0.01	0.38
PS Ratio	4429.97	2126.81	24.42	84.27	37.89	75.87
PB Ratio	2.89	1.39	0.59	1.80	1.07	0.89
P/TBV Ratio	2.91	1.40	0.60	1.81	1.10	0.92
EV/Sales Ratio	-	486.91	-	36.57	4.61	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Asset Turnover	0.00	0.00	0.02	0.02	0.03	0.01
Inventory Turnover	0.11	0.11	2.30	2.05	0.66	1.02
Quick Ratio	12.82	12.82	16.51	23.24	28.26	37.47
Current Ratio	12.88	12.88	16.58	23.52	28.93	38.36
Return on Equity (ROE)	-13.97%	-13.97%	-5.93%	-11.95%	-6.97%	-6.64%
Return on Assets (ROA)	-10.96%	-10.96%	-7.50%	-7.94%	-4.88%	-4.79%
Return on Capital (ROIC)	-11.70%	-11.70%	-7.89%	-8.26%	-5.04%	-4.93%
Earnings Yield	-5.29%	-11.03%	-10.47%	-6.91%	-6.83%	-7.88%
FCF Yield	-	-	-10.88%	-4.60%	-5.21%	-3.38%
Buyback Yield / Dilution	6.75%	6.75%	1.19%	0.96%	-5.53%	1.37%

Updated Aug 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.